
Rapidx Pathology
A diagnostic lab in a bid to expand its footprints in the crucial NCR region and NABL and ICMR- approved diagnostic lab.
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | Acquisition | |
Total Funding | 000k |
Related Content
Rapidx Pathology operates within the healthcare diagnostics sector, focusing on providing comprehensive pathology services. The company aims to deliver accurate and timely diagnostic reports to its clients, which primarily include individual patients, hospitals, and other healthcare providers. The business model appears to be a direct service provider, generating revenue by charging fees for the various diagnostic tests it performs.
The service portfolio of Rapidx Pathology encompasses a wide array of tests, including hematology, biochemistry, clinical pathology, serology, and microbiology. This range of services allows the company to function as a one-stop-shop for many common diagnostic needs. The company emphasizes the use of advanced technology and automated systems to ensure precision and efficiency in its laboratory processes. Reports can be accessed by patients online, a feature designed to enhance convenience and accessibility.
Dr. Pooja Sharma is the director of the company. While details on the specific founding date and the complete founding team are not extensively publicized, the company's operational focus is on making diagnostic services more reliable and patient-centric.
Keywords: pathology services, diagnostic tests, healthcare diagnostics, hematology, biochemistry, clinical pathology, serology, medical laboratory, online reports, healthcare provider